KALVISTA PHARMACEUTICALS INC shareholders Q2 2023

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 96 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.

KALVISTA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Atom Investors LP 33,559$302,0310.12%
DENALI ADVISORS LLC 29,200$262,8000.09%
Leucadia National 1,030,000$9,270,0000.08%
PDT Partners, LLC 37,306$335,7540.05%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,104,339$9,939,0510.02%
FIRST MANHATTAN CO. LLC. 392,504$3,532,5360.01%
Woodline Partners LP 108,358$975,2220.01%
ALGERT GLOBAL LLC 26,290$2370.01%
Jump Financial, LLC 27,142$244,2780.01%
SG Americas Securities, LLC 121,353$1,0920.01%
BOOTHBAY FUND MANAGEMENT, LLC 28,098$252,8820.01%
Connor, Clark & Lunn Investment Management Ltd. 107,975$971,7750.01%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 140,200$1,261,8000.01%
CIBC WORLD MARKETS CORP 50,000$450,0000.00%
Choate Investment Advisors 10,000$90,0000.00%
TWO SIGMA ADVISERS, LP 133,122$1,198,0980.00%
LOS ANGELES CAPITAL MANAGEMENT LLC 72,540$652,8600.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 10,500$94,5000.00%
Renaissance Technologies 142,928$1,2860.00%
TWO SIGMA INVESTMENTS, LP 99,162$892,4580.00%
External links

This page lists KALVISTA PHARMACEUTICALS INC's shareholders in Q2 2023. To view KALVISTA PHARMACEUTICALS INC's shareholder history, click here.